Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01016652 · ClinicalTrials.gov registry record · NA

Clinical Evaluation of a Multifocal Contact Lens on Symptomatic Patients

A NA study of Presbyopia, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
NA
Development phase
49
Enrollment target
8
Study locations

NCT01016652 is a NA study of Presbyopia that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 49 participants, below the 269-participant average among 38 other Presbyopia trials with a reported enrollment target (82% lower). The trial reports 8 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01016652, a NA study of Presbyopia, has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
NA
Development phase
49 participants
Enrollment target
8
Study locations

Study Summary

The purpose of this study is to evaluate the effect of a multi-focal contact lens on symptomatic patients.

Conditions Studied

Interventions

  • DEVICE etafilcon A multifocal contact lens
  • DEVICE etafilcon A Contact Lens

Study Locations (8)

Missouri

  • - Blue Springs
  • - Lake Ozark

Arkansas

  • - North Little Rock

Ohio

  • - Warren

Pennsylvania

  • - Kittanning

Rhode Island

  • - Warwick

South Dakota

  • - Chamberlain

Vermont

  • - Burlington

Trial Details

FieldValue
Enrollment Target 49 participants
Start Date 2009-10-01
Est. Completion 2009-12-01
Phase NA

Sponsor

Johnson & Johnson Vision Care

142 total trials

What the Registry Record Tells You About NCT01016652

The ClinicalTrials.gov registry entry for NCT01016652 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 269-participant average among 38 other Presbyopia trials with a reported enrollment target (82% lower). The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Presbyopia appearing as the primary indexed condition, and to 2 interventions - of which etafilcon A multifocal contact lens is the first listed.

NCT01016652 reports 8 study locations spanning 7 distinct geographic areas - top geographies include Missouri, Arkansas, Ohio.

Frequently Asked Questions

What is clinical trial NCT01016652 about?

NCT01016652 is a clinical study titled "Clinical Evaluation of a Multifocal Contact Lens on Symptomatic Patients". The purpose of this study is to evaluate the effect of a multi-focal contact lens on symptomatic patients.

What is the current status of trial NCT01016652?

This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2009-10-01. Estimated completion is 2009-12-01.

What conditions does trial NCT01016652 study?

This clinical trial studies the following conditions: Presbyopia.

What interventions are being tested in trial NCT01016652?

The interventions under investigation include: etafilcon A multifocal contact lens (DEVICE), etafilcon A Contact Lens (DEVICE).

Who is sponsoring clinical trial NCT01016652?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01016652 being conducted?

This trial has 8 study locations across Arkansas, Missouri, Ohio, Pennsylvania, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Presbyopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.